Phd Thesis Maiti Lommel.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Phd Thesis Maiti Lommel.Pdf PhD-FSTC-2015-60 The Faculty of Sciences, Technology and Communication DISSERTATION Defence held on 04/12/2015 in Luxembourg to obtain the degree of DOCTEUR DE L’UNIVERSITÉ DU LUXEMBOURG EN BIOLOGIE by MAITI LOMMEL Born on 9 January 1988 in Luxembourg (Luxembourg) ANALYSIS OF SIGNAL TRANSDUCTION PATHWAYS LINKING L-PLASTIN SER5 PHOSPHORYLATION TO BREAST CANCER CELL INVASION Dissertation defence committee Dr. Elisabeth Schaffner-Reckinger, Dissertation Supervisor University of Luxembourg Dr. Serge Haan, Dissertation Co-supervisor and Vice Chairman Professor, University of Luxembourg Dr. Thomas Sauter, Chairman Professor, University of Luxembourg Dr. Christophe Ampe Professor, University of Ghent Dr. Guy Berchem Medical Doctor, Luxembourg Institute of Health Analysis of signal transduction pathways linking L-plastin Ser5 phosphorylation to breast cancer cell invasion A dissertation by Maiti Lommel Life Sciences Research Unit, University of Luxembourg Doctoral School in Systems and Molecular Biomedicine Dissertation defence committee: Supervisor: Dr. Elisabeth Schaffner-Reckinger University of Luxembourg, Life Sciences Research Unit, Cytoskeleton and Cell Plasticity Group Co-supervisor: Dr. Serge Haan Professor, University of Luxembourg, Life Sciences Research Unit, Molecular Disease Mechanisms Group Chairman: Dr. Thomas Sauter Professor, University of Luxembourg, Life Sciences Research Unit, Systems Biology Group Members: Dr. Christophe Ampe Professor, University of Ghent, Department of Biochemistry, Molecular Cell Biology and of the Actin Cytoskeleton Group Dr. Guy Berchem Medical Doctor, Luxembourg Institute of Health, Department of Oncology, Laboratory of Experimental Hemato-Oncology Acknowledgements First and foremost I would like to express my deep gratitude to my supervisor, Dr. Elisabeth Schaffner-Reckinger, who has supported me throughout my thesis with a lot of energy and a great enthusiasm for the subject matter. Your guidance and encouragement largely contributed to the completion of my dissertation and I would also like to thank you for your openness and informality which made it a pleasure working with you. I also thank my co-supervisor, Prof. Dr. Serge Haan, for always being available for giving advice and support and I thank Dr. Panuwat Trairatphisan and Prof. Dr. Thomas Sauter for their great collaboration on the modelling part of my dissertation. I also express my gratitude to our collaborators at Ghent University in the groups of Prof. Dr. Christophe Ampe and Prof. Dr. Kris Gevaert for receiving me for a research stay. Special thanks go to Dr. Laurent Vallar from the Luxembourg Institute of Health and his team members (Arnaud Muller, Tony Kaoma, François Bernardin and Petr Nazarov) for their help with the microarray experiments. I am grateful to Christina Laurini, Karoline Gäbler and Alexandre Baron for their meaningful contribution to my experiments and to Monique Wiesinger, Andreas Girod and Sébastien Plançon for their guidance in the P2 lab, in the microscopy and in the flow cytometry facilities respectively. Thanks also go to Nicolas Beaume and Aurélien Ginolhac for their help with statistical data analysis. Big thanks also go to all current and alumni lab members for giving outstanding advice and for creating an enjoyable working atmosphere. I also wish to thank my colleagues from the LSRU for helping out with material and for providing a very pleasant working environment. Thanks also go to Prof. Dr. Evelyne Friederich as an initiator of my research project. I would like to thank Prof. Dr. Christophe Ampe, Dr. Guy Berchem, Prof. Dr. Thomas Sauter, Prof. Dr. Serge Haan and Dr. Elisabeth Schaffner-Reckinger for accepting to be members of my Dissertation Defence Committee. A special thanks also goes to the members of my Dissertation Supervisory Committee, Dr. Thomas Clément and Prof. Dr. Serge Haan, for having accompanied my PhD project. I wish to express my thankfulness to the FNR for financing my thesis. Last but not least, I wish to express my deep gratitude to my family and my friends for their love and support and to my partner, Pit Ullmann, for constructive proofreading of my thesis and for his love and encouragement. Table of contents Abbreviations ......................................................................................................................... 1 Summary…… .......................................................................................................................... 5 Chapter 1 Introduction ....................................................................................................... 6 1.1 The actin cytoskeleton ........................................................................................ 6 1.1.1 Generalities .............................................................................................................. 6 1.1.2 Actin polymerisation ................................................................................................ 7 1.1.3 Actin‐binding proteins (ABPs) ................................................................................... 9 1.1.4 Formation of higher order actin structures .............................................................. 9 1.1.5 Function of higher‐order actin structures .............................................................. 11 1.1.6 Actin cytoskeleton and cancer ............................................................................... 14 1.2 The actin-bundling protein L-plastin .................................................................. 17 1.2.1 L‐plastin structure................................................................................................... 17 1.2.2 L‐plastin regulation and function ........................................................................... 18 1.2.3 L‐plastin phosphorylation and protein phosphorylation in general ...................... 21 1.2.4 L‐plastin interaction partners ................................................................................. 27 1.2.5 L‐plastin and cancer ................................................................................................ 28 1.3 Deregulation of signalling pathways in cancer .................................................. 32 1.3.1 ERK/MAPK pathway activation and activity ........................................................... 33 1.3.2 EGFR signalling in breast cancer ............................................................................. 37 Chapter 2 Aims and outline of the thesis ....................................................................... 41 Chapter 3 Materials and methods ................................................................................... 43 3.1 Cell culture ........................................................................................................ 43 3.2 Antibodies and reagents ................................................................................... 43 3.3 Treatment of cells with pharmacological agents ............................................... 44 3.4 Plasmid constructs ............................................................................................ 44 3.5 Transfections and siRNA knockdown ............................................................... 45 3.6 Immunofluorescence ........................................................................................ 45 3.7 Microarrays ....................................................................................................... 46 3.8 Kinase screening .............................................................................................. 47 3.9 In vitro kinase assays of full-length recombinant L-plastin ............................... 48 3.10 In vitro kinase assay of recombinant glutathione S-transferase (GST)-tagged L-plastin-deltaABD2 ................................................................................................. 48 3.11 Immunoblotting ................................................................................................ 48 3.12 Two-dimensional (2-D) gel electrophoresis ..................................................... 49 3.13 Invasion and migration assays ........................................................................ 50 3.14 Modelling ......................................................................................................... 50 3.15 GFP-Trap ........................................................................................................ 51 3.16 Mass spectrometry .......................................................................................... 51 Chapter 4 Results ............................................................................................................. 53 4.1 Characterisation of four breast cancer cell lines ............................................... 53 4.1.1 Epithelial and mesenchymal signature ................................................................... 53 4.1.2 Epidermal growth factor receptor (EGFR) .............................................................. 59 4.1.3 Migration and invasion capacities .......................................................................... 59 4.1.4 L‐plastin Ser5 phosphorylation levels ..................................................................... 61 4.1.5 Arguments in favour of a breast cancer origin of MDA‐MB‐435S .......................... 61 4.2 Signal transduction cascade leading to L-plastin Ser5 phosphorylation ........... 63 4.2.1 Analysis of protein kinases previously
Recommended publications
  • An Analysis of Legislative Assistance in the European Parliament
    PhD-FLSHASE-2015-12 The Faculty of Language and Literature, Humanities, Arts and Education DISSERTATION Defense held on 27 March 2015 in Luxembourg to obtain the degree of DOCTEUR DE L’UNIVERSITÉ DU LUXEMBOURG EN SCIENCES POLITIQUES by Andreja PEGAN Born on 1 February 1985 in Koper (Slovenia) An Analysis of Legislative Assistance in the European Parliament Dissertation defense committee: Dr. Philippe Poirier, dissertation supervisor Université du Luxembourg Dr. Christine Neuhold Professor, University of Maastricht Dr. Robert Harmsen, Chairman Professor, Université du Luxembourg Dr. Cristina Fasone European University Institute Dr. Olivier Costa, Vice Chairman Professor, Centre Emile Durkheim Sciences Po Bordeaux, College of Europe Brugge Acknowledgements I would like to thank my supervisor Philippe Poirier for giving me the opportunity to do this PhD. Thank you also to Robert Harmsen, David Howarth and Anna-Lena Högenauer from the Political Science Institute. I am grateful to Olivier Costa who served on my Assessment Committee (CET). Morten Egeberg kindly hosted me at the Arena Centre for European Studies and provided me with valuable comments on my research. Assistance given by Guy Vanhaeverbeke has been a great help in the field stage of my research. I am particularly grateful to all the respondents who took the time to speak with me or participated in the online survey. This research was supported by the National Research Fund Luxembourg (FNR) under the funding scheme Aides à la Formation Recherche (AFR) (Project number 1080494). My
    [Show full text]
  • Recent Trends in Public-Sector Performance and Productivity in Europe
    Recent Trends in Public-sector Performance and Productivity in Europe First published in Japan by the Asian Productivity Organization Leaf Square Hongo Building 2F 1-24-1 Hongo, Bunkyo-ku Tokyo 113-0033, Japan www.apo-tokyo.org © 2016 Asian Productivity Organization Asian Productivity Organization (APO) or any APO member. The views expressed in this publication do not necessarily reflect the official views of the All rights reserved. None of the contents of this publication may be used, reproduced, stored, or transferred in any form or by any means for commercial purposes without prior written permission from the APO. i CONTENTS Acknowledgement iii Executive Summary 1 1. Introduction, Background, and Key Learning Points 3 2. First Public-sector Performance Study Mission in Europe 8 3. Case Studies and Learning Points 10 Delegates 12 4. Summary of Key Benefits and Learning Points by Study Mission 5. European Public-sector Initiatives: Evolution and Recent Trends and Topics at the 8QC 15 6. The EIPA 20 7. The CAF 21 8. Key Learning Points on the CAF by Study Mission Delegates 23 9. Conclusions and Recommendations to the APO 24 References 29 Figures Figure 1. APO PSP Program framework. 6 Figure 2. Study mission map. 8 Figure 3. Delegate feedback on the study mission. 13 Figure 4. OECD toolbox overview by theme and topic. 18 Figure 5. The CAF model. 21 Annex 1. Site Visits and Presentation Reports 30 Annex 2. Report on the APO Study Mission on Recent Trends in Public-sector Productivity and Performance in Europe (Belgium, the Netherlands, Germany, and Luxembourg) from September 27 to October 2, 2015 under the APO Development of Center of Excellence by Magdalena L.
    [Show full text]
  • Luxembourg's Development Cooperation Annual Report 2015
    Luxembourg’s development cooperation Annual report 2015 Lëtzebuerger Entwécklungszesummenaarbecht www.cooperation.lu There is also an independent microsite containing the annual reports on Luxembourg’s development cooperation since 2010 at the following address: www.cooperation.lu. Table of contents Annual report 2015 4 Introduction by the Minister 7 Meetings and trips in 2015 11 European Year for Development 14 COP21 and the Paris Agreement 16 I. Luxembourg’s official development assistance in 2015 26 II. Cooperation with the main partner countries 26 The new Indicative Cooperation Programmes and the focus on least developed countries 29 Africa 29 Burkina Faso 30 Cabo Verde 31 Mali 32 Niger 33 Senegal 34 Central America 34 El Salvador 35 Nicaragua 36 Asia 36 Laos 37 Vietnam 38 III. Regional cooperation and cooperation with other countries 40 Balkans (Kosovo – Montenegro – Serbia) 40 Mongolia 41 Myanmar 42 Occupied Palestinian Territories 43 Afghanistan/Tajikistan 44 IV. Multilateral cooperation 53 V. European Union 55 VI. Cooperation with development NGOs 59 VII. Humanitarian action 67 VIII. Programme support 69 IX. Development education and awareness raising 70 X. Inclusive finance 71 XI. Evaluation 73 XII. Report on the progress of the work of the Interministerial Committee 77 Appendices 77 A. Useful addresses 79 B. Organisational chart of the Directorate for Development Cooperation 81 C. Useful links 3 Introduction by the Minister Dear friends of Luxembourg’s development cooperation, It is my pleasure to present to you this annual report 2015 on Luxembourg de- velopment cooperation. In last year’s annual report I highlighted the fact that 2015 would be a pivotal year for development cooperation and that the major international meetings would to a large extent reconfigure our post-2015 devel- opment cooperation and its financing.
    [Show full text]
  • Financial Mechanisms for Innovative Social and Solidarity Economy Ecosystems
    Financial Mechanisms for Innovative 100 Social and Solidarity Economy 95 Ecosystems 75 25 5 0 Cover_BASE 11 November 2019 09:30:13 Financial Mechanisms for Innovative Social and Solidarity Economy Ecosystems Samuel Barco Serrano1, Riccardo Bodini2, Michael Roy,3 Gianluca Salvatori4 1 Co-founder and CEO, SOKIO Cooperative. 2 Director, Euricse. 3 Professor of Economic Sociology and Social Policy, Yunus Centre for Social Business and Health/Glasgow Schoof for Business and Society, Glasgow Caledonian University. 4 Secretary General, Euricse. Copyright © International Labour Organization 2019 First published 2019 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Licensing), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: [email protected]. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with a reproduction rights organization may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ________________________________________________________________________________________________________ Financial mechanisms for innovative social and solidarity economy ecosystems –
    [Show full text]
  • Benchmarking Working Europe 2018 ETUI Publications Are Published to Elicit Comment and to Encourage Debate
    European List Trade Union Institute Boulevard du Roi Albert II, 5, box 4 of country B-1210 Brussels Benchmarking codes + 32 (0)2 224 04 70 [email protected] www.etui.org AT Austria Working Europe BE Belgium European BG Bulgaria Trade Union Confederation Boulevard du Roi Albert II, 5 CH Switzerland B-1210 Brussels 2018 CY Cyprus CZ Czech Republic + 32 (0)2 224 04 11 [email protected] DE Germany www.etuc.org DK Denmark EE Estonia ES Spain FI Finland FR France GR Greece HR Croatia HU Hungary IE Ireland IT Italy LT Lithuania LU Luxembourg LV Latvia MT Malta NL Netherlands NO Norway PL Poland PT Portugal RO Romania SE Sweden SI Slovenia SK Slovakia UK United Kingdom US United States EA EU Member States (19) that adopted the euro before 2016 EU13 EU ‘new’ Member States that joined the EU after 2004 EU15 EU Member States that joined the EU before 2004 EU27 EU Member States that joined the EU ISBN: 978-2-87452-469-1 before 2012 D/2018/10.574/04 EU28 EU Member States that joined the EU before 2014 List The European The European of country Trade Union Institute Trade Union Confederation codes (ETUI) (ETUC) AT Austria BE Belgium The ETUI conducts research in areas of The institute’s work is organised in The European Trade Union The ETUC is the only social partner BG Bulgaria relevance to the trade unions, including accordance with the following five common Confederation (ETUC) exists to speak representing workers at European CH Switzerland the labour market and industrial relations, priorities: with a single voice, on behalf of the level in the framework of the European and produces European comparative — Policies and actions for the future of common interests of workers, at social dialogue.
    [Show full text]
  • 2015 Activity Report
    lkjlkjhjhhon–– 2015 Activity Report 2015 Activity Report www.orpha.net Table of contents Abbreviation list ........................................................................................................................... 4 1. Overview .............................................................................................................................. 6 1.1. Objective .................................................................................................................................... 6 1.2. Activities ..................................................................................................................................... 6 1.3. Highlights of 2015 ...................................................................................................................... 7 Orphanet international positioning ............................................................................................... 7 Improving transparency and traceability ....................................................................................... 7 Orphanet database updates ........................................................................................................... 7 Orphanet documents update ......................................................................................................... 7 Orphanet website information ...................................................................................................... 8 Codification of RD using ORPHA codes .........................................................................................
    [Show full text]
  • Luxembourg Presidency Conclusions 2015-11-27 (Final)
    27 November 2015 PRESIDENCY CONCLUSIONS of the Luxembourg Presidency of the Council of the European Union on the occasion of the Informal Ministerial Meetings on Territorial Cohesion and Urban Policy Luxembourg, 26 and 27 November 2015 At the invitation of the Luxembourg Presidency of the Council of the European Union, the Informal Ministerial Meeting on Territorial Cohesion took place in Luxembourg on 26 November 2015 and the Informal Ministerial Meeting on Urban Policy took place in Luxembourg on 27 November 2015. The Ministers responsible for Territorial Cohesion and Urban Policy in the European Union, together with the Commissioner for Regional Policy of the European Commission, the Chair of the Committee on Regional Development of the European Parliament, the President of the European Committee of the Regions, the President of the ECO Section of the European Economic and Social Committee, representatives of the European Investment Bank, representatives from Serbia and Turkey as well as Norway and Switzerland, and representatives of relevant stakeholder organisations and several observers, (1) Considering that in the framework of intergovernmental cooperation the Territorial Agenda 2020 was decided with the aim of promoting and enhancing an integrated and place-based territorial approach to support territorial cohesion, and was subject to an evaluation of the necessity to be reviewed under the Latvian and Luxembourg Presidencies; territorial cohesion was considered as a new EU objective in the Lisbon Treaty and the Treaty has now
    [Show full text]
  • Annual Report 2015
    ECPC ANNUAL REPORT 2015 "Nothing about us without us!" TABLE OF CONTENTS ECPC: Rising to new heights .............................................................................................. 4 ECPC Annual general meeting 2015 ........................................................................................... 4 Enhanced collaboration with an increased ECPC member base ................................................... 4 Make Sense Campaign ..................................................................................................................... 5 Guide for patients on immuno-oncology ......................................................................................... 5 Nutrition Survey ............................................................................................................................... 5 The Brain Tumour Charity ................................................................................................................ 5 Lung Cancer Europe (LuCE) .............................................................................................................. 5 PAVEL ............................................................................................................................................... 6 ECPC Staff ................................................................................................................................. 6 Financial Officer ..............................................................................................................................
    [Show full text]
  • Access to Healthcare for People Facing Multiple Vulnerabilities in Health in 31 Cities in 12 Countries
    © Olmo CALVO/ Médicos del Mundo © Olmo CALVO/ Welcoming refugees in Europe Access to healthcare for people facing multiple vulnerabilities in health in 31 cities in 12 countries C : 100 M : 60 J : 0 N : 0 NovemberMédecins du monde - Identité visuelle ANGLETERRE 08/07/2009 2016 TABLE OF CONTENTS 3/ ACKNOWLEDGMENTS 27/ BARRIERS IN ACCESS TO HEALTHCARE 4/ EXECUTIVE SUMMARY Overview 27 5/ 2015 IN FIGURES Giving up seeking medical European survey results (11 countries) 5 advice or treatment 30 Key figures for Turkey 5 Denial of access to care by a health provider 30 Focus: Pregnant women 5 Discrimination in healthcare facilities 30 Focus: Children 6 Fear of being arrested 30 Focus: Violence 6 31/ SELF-PERCEIVED HEALTH STATUS 7/ EUROPEAN NETWORK AND INTERNATIONAL OBSERVATORY 32/ HEALTH STATUS 7/ THE SOCIAL, ECONOMIC Health problems 32 AND POLITICAL CONTEXT IN 2015 Contraception 32 Urgent care 32 10/ RECENT LEGAL CHANGES, Acute and chronic health conditions 33 FOR BETTER OR WORSE Necessary treatment 33 France 10 Patients had received little or Germany 10 no care before visiting our clinics 33 Greece 10 Chronic conditions: Luxembourg 10 no access, no continuity 34 Norway 10 Infectious disease screening 34 Spain 10 Sweden 11 36/ FOCUS ON PREGNANT WOMEN Switzerland 11 Geographic origin of pregnant women 37 Turkey 11 Administrative status 37 United Kingdom 11 Living conditions 37 Isolation 37 12/ 2015 INTERNATIONAL Limiting movements 37 OBSERVATORY SURVEY HIV and hepatitis screening 38 Methodology 12 Access to healthcare 38 Statistics 12 Pregnant
    [Show full text]
  • Work Package 6 Policy Watch High Level Policy Forum Report 2
    WORK PACKAGE 6 POLICY WATCH HIGH LEVEL POLICY FORUM REPORT 2 ASSET Project • Grant Agreement N°612236 ASSET Action plan on SiS related issues in Epidemics And Total Pandemics 7th RTD framework programme Theme: [SiS.2013.1.2-1 Sis.2013.1.2-1] Responsible partner: TIEMS Contributing partners: ISS, DBT, FFI, NCIPD, EIWH Nature: Report Dissemination: PU Contractual delivery date: 2016-12-31 (m36) Submission Date: 2016-12-31 This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236. This DOCUMENT MANAGEMENT PROJECT FULL TITLE Action plan on SiS related issues in Epidemics And Total Pandemics PROJECT ACRONYM ASSET Coordination and Support Action: project funded under Theme SiS.2013.1.2 “Mobilization and Mutual Learning (MML) Action Plans” GRANT AGREEMENT 612236 STARTING DATE 2014-1-1 DURATION 48 months D6.2 High Level Policy Forum Report 2 Task: 6.1 Leader: TIEMS – Other contributors: ISS, DBT,FFI,NCIPD,EIWH History of changes: Vn Status Date Organization / Person Reason for Change responsible V1 Draft 2016-2-1 TIEMS Draft for comment V2 Interim 2016-2-10 TIEMS Report of activities through January 2016 V3 Draft 2016-12-31 TIEMS Draft Report of activities through December 2016 V4 Final 2017-1-26 TIEMS Final Deliverable D6.2 2 Table of Contents EXECUTIVE SUMMARY .................................................................................................................................... 4 1. INTRODUCTION .............................................................................................................................................
    [Show full text]
  • Overview Report on the State of the Art of Rare Disease Activities in Europe
    Overview Report on the State of the Art of Rare Disease Activities in Europe 2016 Version RD-ACTION WP6 RD-ACTION WP6 Output RD-ACTION WP6 1 Authors: V. Hedley; H. Murray; C. Rodwell*, S. Ayme* In certain sections, especially those describing the origins of rare disease policies in Europe, the RD-ACTION-led State of the Art resource has retained text generated by Prof. Aymé and Ms Rodwell under the EUCERD Joint Action, and thus they should be considered co-authors of the current document. Disclaimer: The findings and conclusions in this report are those of the contributors and validating authorities, who are responsible for the contents; the findings and conclusions do not necessarily represent the views of the European Commission or national health authorities in Europe. Therefore, no statement in this report should be construed as an official position of the European Commission or a national health authority. Background to the State of the Art of Rare Disease Activities in Europe: The Report on the State of the Art of Rare Disease activities in Europe is a well-established resource providing valuable, detailed information for all stakeholders in the field of rare diseases and orphan medicinal products. It highlights activities and progress at both the European Union (EU) and Member State (MS) levels. Under the EUCERD Joint Action the report was produced by the INSERM team in Paris, in five volumes. This was a substantial report, downloaded 15,000 times per annum and divided into five volumes. Under the subsequent Joint Action, RD-ACTION (2015-18) production of the State of the Art resource moved to Newcastle University and it was agreed that two versions of the ‘Overview report’ (the current document) would be produced in the project lifetime: this overview report will be complemented by Member State-specific webpages under the main RD- ACTION site, detailing activities at the national level.
    [Show full text]
  • Annual Report for the Polish Presidency Empowering Cooperation in the Baltic Sea Region Sustainability Creativity Safety
    CBSS Council of the Baltic Sea States: From Idea to Action: Annual Report for the Polish Presidency Empowering Cooperation in the Baltic Sea Region Sustainability Creativity Safety Synergy Poland enhanced coherence and synergy in Diversity among various stakeholders in the Baltic Sea Region, including the European Union Strategy for the Baltic Sea Region, by organising three Joint Meetings. Poland chaired the European Union Strategy for the Baltic Sea Region National Coordinators meetings from July 2015 till June 2016 and the VASAB Committee from July 2015 till December 2016. Poland also chaired the Steering Committee of the Northern Dimension Partnership on Culture (NDPC) until September 2015 and took over the chairmanship of the Steering Committee of the Northern Dimension Partnership on Transport and Logistics (NDPTL) for the year 2016. Poland revived the political dialogue in the region by organising meetings of Deputy Foreign Ministers, Ministers for Culture and, for the first time in history of the organisation, Ministers for Science. Poland inspired a thorough discussion on the future of the CBSS and the Baltic Sea Region as a whole. Poland put a lot of emphasis on making the cooperation more efficient and easily accessible to all stakeholders, also by promoting video link participation in the meetings. Table of Contents Foreword of the Polish Polish Polish Chair Presidency Presidency Outcomes Highlights 02 04 07 Other Activities Recommendations Committee of of the Polish of the Polish Senior Officials Presidency Presidency 16
    [Show full text]